Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder. Koc ER, Yetkin MF, Saridas F, Turan OF, et al. J Neurol 2026;273:67.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Koc ER, Yetkin MF, Saridas F, Turan OF, et al. Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder. J Neurol 2026;273:67.
PMID: 41504930